- Home
- UCAR vs IMRN Comparison
UCAR vs IMRN Comparison
Compare UCAR & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCAR
- IMRN
- Stock Information
- Founded
- UCAR 2013
- IMRN 1994
- Country
- UCAR China
- IMRN Australia
- Employees
- UCAR N/A
- IMRN N/A
- Industry
- UCAR Retail-Auto Dealers and Gas Stations
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- UCAR Consumer Discretionary
- IMRN Health Care
- Exchange
- UCAR Nasdaq
- IMRN Nasdaq
- Market Cap
- UCAR 10.1M
- IMRN 9.2M
- IPO Year
- UCAR 2023
- IMRN N/A
- Fundamental
- Price
- UCAR N/A
- IMRN $2.05
- Analyst Decision
- UCAR Strong Buy
- IMRN
- Analyst Count
- UCAR 1
- IMRN 0
- Target Price
- UCAR $5.00
- IMRN N/A
- AVG Volume (30 Days)
- UCAR 129.2K
- IMRN 74.8K
- Earning Date
- UCAR 05-15-2026
- IMRN 08-29-2025
- Dividend Yield
- UCAR N/A
- IMRN N/A
- EPS Growth
- UCAR N/A
- IMRN N/A
- EPS
- UCAR N/A
- IMRN N/A
- Revenue
- UCAR $6,816,075.00
- IMRN $4,777,422.00
- Revenue This Year
- UCAR N/A
- IMRN N/A
- Revenue Next Year
- UCAR N/A
- IMRN N/A
- P/E Ratio
- UCAR N/A
- IMRN N/A
- Revenue Growth
- UCAR 57.22
- IMRN 48.63
- 52 Week Low
- UCAR $1.74
- IMRN $1.50
- 52 Week High
- UCAR $9.43
- IMRN $2.48
- Technical
- Relative Strength Index (RSI)
- UCAR 41.04
- IMRN 56.45
- Support Level
- UCAR $1.93
- IMRN $2.02
- Resistance Level
- UCAR $2.12
- IMRN $2.30
- Average True Range (ATR)
- UCAR 0.10
- IMRN 0.11
- MACD
- UCAR 0.01
- IMRN -0.00
- Stochastic Oscillator
- UCAR 36.04
- IMRN 47.53
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.